STOCKHOLDERS' EQUITY (Details 1) - $ / shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| STOCKHOLDERS' EQUITY | ||
| Non-vested as of December 31, 2024 | 140,221 | |
| Granted | 38,378 | |
| Vested | (143,720) | |
| Non-vested as of March 31, 2025 | 34,879 | 140,221 |
| Non-vested Weighted average grant date fair value per share beginning | $ 7.96 | $ 0 |
| Granted | 21.50 | 0 |
| Vested | 8.73 | 0 |
| Non-vested Weighted average grant date fair value per share ending | $ 19.67 | $ 7.96 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
| X | ||||||||||
- References No definition available.
|